Latest papers

Results for “transfusion cardiac restrictive OR transfusion cardiac liberal”.

Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.

AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.

Last successful paper check: 16 Nov 2026 17:18 UTC. 0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
Article J Clin Anesth Published 31 Oct 2026
Cell salvage volume and hemostatic changes in cardiac surgery: A retrospective cohort study using routine coagulation and viscoelastic assessment.
AI-generated abstract summary · verify against the original paper
  • Retrospective cohort of adult cardiac surgery patients using cell salvage, analyzed as a routine coagulation cohort (N = 677) and an exploratory viscoelastic cohort (N = 50).
  • Exposure was cell salvage reinfusion volume, with paired hemostatic measurements before and after and no coagulation-affecting blood products between them.
  • In the routine coagulation cohort, CS volume was not significantly associated with absolute changes in any parameter (all p ≥ 0.144).
  • In the viscoelastic cohort, higher CS volume was associated with lower functional fibrinogen clot strength (CFF MA β = -3.31 mm/L; 95% CI -5.53 to -1.08; adjusted p = 0.031), while the CK MA association did not survive correction.
PubMed indexed 31 Oct 2026 Imported 9 Nov 2026 Aranbitski R et al. Publisher Cardiac
Article J Clin Med Published 30 Oct 2026
An Integrated ERAS-PBM Pathway for Cardiac Surgery: Insights and Outcomes.
AI-generated abstract summary · verify against the original paper
  • This single-center, retrospective before-after study compared 229 elective cardiac surgery patients on an ERAS-PBM pathway with 162 pre-ERAS patients from 2019.
  • The ERAS-PBM pathway added preoperative anemia screening and treatment, adherence to restrictive transfusion thresholds, blood conservation, and care bundles run by an ERAS nurse.
  • RBC transfusion fell from 38.9% to 23.6% (p = 0.0012), and the exploratory adjusted OR for transfusion was 0.59 (95% CI 0.36-0.98; p = 0.041).
  • Complications fell from 66.7% to 46.3% and hospital stay shortened from 12 to 9 days, and the authors call for larger multicenter prospective studies.
PubMed indexed 14 Nov 2026 Imported 14 Nov 2026 Lavanchy L et al. Publisher CardiacPerioperative medicine
Review Blood Transfus Published 28 Oct 2026
Perioperative hemostatic therapy in adult cardiac surgery: a narrative review highlighting human factors.
AI-generated abstract summary · verify against the original paper
  • This narrative review synthesizes fourteen original studies covering nearly 220,000 patients from over 1,000 centres worldwide.
  • It focuses on platelet concentrate and fresh frozen plasma use in adult cardiac surgery and how hemostatic therapy varies between centres.
  • Platelet and plasma transfusion rates differed significantly across centres, and patient and procedural characteristics do not fully explain these differences.
  • Viscoelastic tests have improved assessment in some settings but have not eliminated variation, which the authors attribute partly to hospital culture, organization, thresholds and human factors.
PubMed indexed 2 Nov 2026 Imported 9 Nov 2026 Sebestyen A et al. Publisher CardiacPerioperative medicine
RCT Bone Jt Open Published 19 Oct 2026
RESULT-Hip. The impact of restrictive compared with liberal transfusion strategy on cardiac injury and death in patients undergoing surgery for hip fracture : protocol for a multicentre, randomized controlled trial of two blood transfusion strategies.
AI-generated abstract summary · verify against the original paper
  • Protocol for a multicentre randomized controlled trial in patients aged 60 or older with anaemia (haemoglobin ≤90 g/l) undergoing surgery for hip fracture.
  • Compares a liberal transfusion strategy (haemoglobin target 90 to 110 g/l) with a restrictive strategy (target 75 to 90 g/l) from randomization to discharge or 30 days.
  • No efficacy results are reported; the primary outcome is a composite of death or major adverse cardiac events, adjudicated by blinded experts, with quality of life assessed at 120 days.
  • The authors reduced the target sample size from 1,984 to 842 and added myocardial injury after non-cardiac surgery (MINS) to the primary outcome after recruitment fell short.
PubMed indexed 18 Oct 2026 Imported 9 Nov 2026 RESULT Hip Study Group et al. Publisher Perioperative medicine